RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+49.81%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$5.42B
AUM Growth
+$5.42B
(+52%)
Cap. Flow
+$755M
Cap. Flow
% of AUM
13.95%
Top 10 Holdings %
Top 10 Hldgs %
46.89%
Holding
89
New
20
Increased
11
Reduced
36
Closed
9
Top Buys
| 1 |
ADC Therapeutics
ADCT
|
$259M |
| 2 |
BioNTech
BNTX
|
$193M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
$124M |
| 4 |
Pliant Therapeutics
PLRX
|
$111M |
| 5 |
Zentalis Pharmaceuticals
ZNTL
|
$79.8M |
Top Sells
| 1 |
Biogen
BIIB
|
$114M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$75.7M |
| 3 |
uniQure
QURE
|
$68.8M |
| 4 |
Tandem Diabetes Care
TNDM
|
$56.7M |
| 5 |
Centene
CNC
|
$49M |
Sector Composition
| 1 | Healthcare | 93.05% |
| 2 | Industrials | 1.02% |
| 3 | Financials | 0.23% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Fate Therapeutics
FATE
$120M
| $433M | 8% | 12,629,737 +1,412,928 | +13% | +$48.5M |
|
2
Amicus Therapeutics
FOLD
$2.34B
| $376M | 6.94% | 24,944,695 -236,805 | -0.9% | -$3.57M |
|
|
DCPH
3
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $297M | 5.49% | 4,978,941 -137,322 | -3% | -$8.2M |
|
|
4
ADC Therapeutics
ADCT
$345M
| $259M | 4.78% | +5,525,870 | New | +$259M |
|
5
argenx
ARGX
$43.6B
| $233M | 4.3% | 1,034,868 -47,202 | -4% | -$10.6M |
|
|
IGMS
6
DELISTED
IGM Biosciences
IGMS
| $230M | 4.24% | 3,144,000 | – | – |
|
|
7
BioNTech
BNTX
$24B
| $205M | 3.78% | 3,069,164 +2,898,964 | +1,703% | +$193M |
|
|
ALLK
8
DELISTED
Allakos
ALLK
| $188M | 3.47% | 2,619,080 -357,848 | -12% | -$25.7M |
|
|
PRNB
9
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $162M | 2.99% | 2,712,388 +451,300 | +20% | +$27M |
|
|
MNTA
10
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $157M | 2.89% | 4,705,308 -469,700 | -9% | -$15.6M |
|
|
EPZM
11
DELISTED
Epizyme, Inc
EPZM
| $136M | 2.52% | 8,485,605 -282,870 | -3% | -$4.54M |
|
|
IMMU
12
DELISTED
Immunomedics Inc
IMMU
| $124M | 2.28% | +3,489,900 | New | +$124M |
|
|
13
Pliant Therapeutics
PLRX
$101M
| $111M | 2.04% | +3,410,657 | New | +$111M |
|
|
ONEM
14
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| $109M | 2.02% | 3,010,684 -112,700 | -4% | -$4.09M |
|
15
Atara Biotherapeutics
ATRA
$84.6M
| $99.7M | 1.84% | 6,843,370 +1,550,000 | +29% | +$22.6M |
|
16
Beam Therapeutics
BEAM
$1.66B
| $94M | 1.74% | 3,356,958 -2,300 | -0.1% | -$64.4K |
|
17
Cigna
CI
$80.3B
| $91.2M | 1.68% | 486,100 +185,500 | +62% | +$34.8M |
|
18
Aprea Therapeutics
APRE
$9.09M
| $88M | 1.62% | 2,268,718 | – | – |
|
19
Regenxbio
RGNX
$451M
| $82.4M | 1.52% | 2,236,766 -101,700 | -4% | -$3.75M |
|
|
20
Zentalis Pharmaceuticals
ZNTL
$122M
| $79.8M | 1.47% | +1,661,205 | New | +$79.8M |
|
21
Replimune Group
REPL
$422M
| $77.1M | 1.42% | 3,104,193 +123,700 | +4% | +$3.07M |
|
22
Repare Therapeutics
RPTX
$71.7M
| $74M | 1.37% | +2,386,174 | New | +$74M |
|
|
GNMK
23
DELISTED
GenMark Diagnostics, Inc
GNMK
| $72.1M | 1.33% | +4,903,400 | New | +$72.1M |
|
24
Neurogene
NGNE
$264M
| $67.1M | 1.24% | 4,041,211 | – | – |
|
|
HRC
25
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $64.2M | 1.19% | +585,000 | New | +$64.2M |
|